CMC Committee

The CMC Committee educates members and provides expertise on issues related to gene and cell therapy Chemistry, Manufacturing, and Control (CMC). The Committee recommends programming for the Annual Meeting and other educational events, and supports the Regulatory Affairs Committee to interact with FDA on CMC-related topics.
Full NamePositionOrganizationTerm StartTerm End
Data pager
Data pager
12
Page size:
 31 items in 2 pages
Show all 31
Sadik Kassim, PhDChairDanaher (Genomic Medicines)6/1/20265/31/202753689
Mercedes Segura GallyMemberEditas Medicine, Inc.6/1/20265/31/2029112694
Basak Clements, CMC ProfessionalMemberBiomatria Consulting6/1/20265/31/202999323
Tania Catarino RibeiroMemberImmunoScape6/1/20265/31/2029103292
Cecilia TamiMemberGenentech, Inc8/31/20235/31/202961343
Folashade Otegbeye, MBChB, MPHMemberFred Hutchinson Cancer Center6/1/20265/31/202998884
Akriti VirdiMemberREGENXBIO Inc.6/1/20245/31/202763221
Stuart Nelson, MSMemberEli Lilly and Company6/1/20245/31/202740137
SUPREET KHANAL, PhDMemberUS Food and Drug Administration6/1/20265/31/202955761
Sanjin ZvonicMemberDark Horse Consulting Group6/1/20255/31/202865774
Franz M. Gerner, PhDMemberSouth Mountain Advanced Therapy Consultants, LLC6/1/20255/31/20281464
Sofia Haakansson Buch, PhDMemberNovo Nordisk A/S6/1/20255/31/202859424
Daniel KotaMemberHouston Methodist Research Institute6/1/20235/31/202956785
Angela S. Whatley, PhDMemberInsmed6/1/20245/31/202727833
Markus J. Haindl, PhDMemberRoche6/1/20245/31/202738857
SUPREET KHANAL, PhDMemberUS Food and Drug Administration6/1/20265/31/202955761
John P. Tomtishen III, IIIMemberCatalent6/1/20265/31/202725790
Mercedes Segura GallyMemberEditas Medicine, Inc.6/1/20265/31/2029112694
Tayler SheblyMemberEli Lilly6/1/20245/31/202754892
Daniel LeblancMemberEnsoma6/1/20255/31/202848183